Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Yaqoot Fatima, Professor of Sleep Health, University of the Sunshine Coast

The weight loss drug Mounjaro has been approved to treat sleep apnoea. How does it work?

coldsnowstorm/Getty Images

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.

The TGA has indicated Mounjaro can be used to treat moderate to severe obstructive sleep apnoea in adults with obesity (a body-mass index of 30 or above).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.